Cargando…

Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer

Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive neoplasia lacking the expression of hormonal receptors and human epidermal growth factor receptor-2. Accumulating evidence has highlighted the importance of miRNAs dysregulation in the establishment of cancer programs, but the fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero-Cordoba, Sandra L., Rodriguez-Cuevas, Sergio, Bautista-Pina, Veronica, Maffuz-Aziz, Antonio, D’Ippolito, Elvira, Cosentino, Giulia, Baroni, Sara, Iorio, Marilena V., Hidalgo-Miranda, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095912/ https://www.ncbi.nlm.nih.gov/pubmed/30115973 http://dx.doi.org/10.1038/s41598-018-29708-9

Ejemplares similares

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Identification and Pathway Analysis of microRNAs with No Previous Involvement in Breast Cancer
por: Romero-Cordoba, Sandra, et al.
Publicado: (2012)

Correction: Identification and Pathway Analysis of microRNAs with No Previous Involvement in Breast Cancer
por: Romero-Cordoba, Sandra, et al.
Publicado: (2015)

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer
por: Cataldo, Alessandra, et al.
Publicado: (2020)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
por: Baroni, S, et al.
Publicado: (2016)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
por: Forte, Luca, et al.
Publicado: (2018)

Phyllodes Tumor of the Breast: 307 Treated Cases, the Largest Mexican Experience at a Single Breast Disease Institution
por: Ruvalcaba-Limón, Eva, et al.
Publicado: (2016)

Medium Chain Triglyceride (MCT) Oil Affects the Immunophenotype via Reprogramming of Mitochondrial Respiration in Murine Macrophages
por: Yu, Seungmin, et al.
Publicado: (2019)

Health Tract No. 342: Lunacy
Publicado: (1868)

Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression
por: Tseng, H-Y, et al.
Publicado: (2017)

The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation
por: Yang, Wenjie, et al.
Publicado: (2021)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

La importancia e influencia del liderazgo en el medio empresarial
por: Maffuz Pérez, Alfredo
Publicado: (1996)

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells
por: Saulle, Ernestina, et al.
Publicado: (2021)

Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma
por: Thakur, A., et al.
Publicado: (2020)

Hyperoxia induces glucose metabolism reprogramming and intracellular acidification by suppressing MYC/MCT1 axis in lung cancer
por: Liu, Xiucheng, et al.
Publicado: (2023)

MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells
por: Duan, Xianxian, et al.
Publicado: (2022)

miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts
por: Cosentino, Giulia, et al.
Publicado: (2020)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016)

Expression of long non‐coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple‐negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death
por: Beltrán‐Anaya, Fredy Omar, et al.
Publicado: (2019)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation
por: Sáenz-de-Santa-María, Inés, et al.
Publicado: (2017)

FRI342 Hypophysitis Mimicking As Pituitary Adenoma
por: Chao, Alex, et al.
Publicado: (2023)

SAT342 Stress-induced Cardiomyopathy And Pheochromocytoma
por: Rivas Pajuelo, Cynthia G
Publicado: (2023)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4
por: Martinez-Outschoorn, Ubaldo E, et al.
Publicado: (2013)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
por: Castagnoli, Lorenzo, et al.
Publicado: (2019)

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
por: Romero-Cordoba, Sandra, et al.
Publicado: (2019)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment
por: Nuñez-Olvera, Stephanie I., et al.
Publicado: (2022)

Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Marked Seizure Reduction after MCT Supplementation
por: Azzam, Raed, et al.
Publicado: (2013)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
por: Skaripa-Koukelli, Irini, et al.
Publicado: (2021)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tu5pej2oibeulcvu28iaq50k05